first glp 1 approval Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment The FDA has approved the

10.3389/fendo.2023.1244432 131 XuG.StoffersD

VCU Health Expert Shares Tips for Mitigating Side Effects from Weight Loss Drugs

Sources Endocrine Society Consuming more protein may protect patients taking an anti-obesity drug from muscle loss endocrine.org University of Utah Health Want to Lose Weight

Meanwhile, new GLP-1/GIP dual receptor agonists have been proven effective in neuroprotection and mechanisms in PD, such as DA-JC1 (DA1), DA-JC4 (DA4), and DA-CH5 (DA5) in MPTP-induced PD models

Stable blood sugar slow carbs prevent crashes that spike hunger hormones

The study concluded that a gastric emptying delay of around 36 min (scintigraphy) in patients on GLP-1 RAs would not have a great impact on the standard fasting time of 68 h, and hence these medications can be continued in the perioperative period